Skip to main content
Journal cover image

Higher Use of Surgery Confers Superior Survival in Stage I Non-Small Cell Lung Cancer.

Publication ,  Journal Article
Mulvihill, MS; Cox, ML; Becerra, DC; Watson, JA; Voigt, SL; Yerokun, BA; Speicher, PJ; D'Amico, TA; Tong, B; Hartwig, MG
Published in: Ann Thorac Surg
November 2018

BACKGROUND: Lobar resection is the gold standard therapy for medically fit patients with stage I non-small cell lung cancer (NSCLC). However, considerable variability exists in the use of surgical therapy. This study tested the hypothesis that center-based variation in the use of surgical therapy affects survival in NSCLC. METHODS: We queried the National Cancer Database for patients with stage I NSCLC. Mixed-effects multivariable models were developed to establish the per-center adjusted rate of surgical therapy. Patients were stratified into quartiles based on the treating center's adjusted rate of surgical therapy. Survival was estimated and then tested by using Kaplan-Meier and the log-rank test. Multivariable Cox proportional hazard models were developed to estimate the effect of rate of surgical therapy on overall survival. RESULTS: A total of 139,802 patients met the criteria. There was wide variation in the per-center rate of surgical resection in the highest (80.8%) versus lowest (41.4%, p < 0.001) quartile. Across cohorts, patients were similar in age (mean 68.8 years in the highest quartile versus 69.7 in the lowest quartile) and Charlson-Deyo Score of 2 or greater (15.1% in the highest quartile versus 14.4% in the lowest quartile). Five-year survival was higher for patients treated at high-use centers (52.7% versus 36.7%, p < 0.001). After adjustment, an adjusted rate of surgical therapy in the lowest 25th percentile was associated with lower survival (adjusted hazard ratio 1.40, 95% confidence interval: 1.37 to 1.40, p < 0.001). CONCLUSIONS: Treatment at a center with a higher rate of surgical therapy confers a considerable survival advantage, even after adjustment for hospital volume, surgical approach, and other confounders. Targeted efforts to improve adherence to guidelines about provision of surgical therapy in early-stage NSCLC may represent a meaningful opportunity to improve outcomes.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Ann Thorac Surg

DOI

EISSN

1552-6259

Publication Date

November 2018

Volume

106

Issue

5

Start / End Page

1533 / 1540

Location

Netherlands

Related Subject Headings

  • United States
  • Treatment Outcome
  • Survival Analysis
  • Risk Assessment
  • Retrospective Studies
  • Respiratory System
  • Proportional Hazards Models
  • Prognosis
  • Pneumonectomy
  • Multivariate Analysis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Mulvihill, M. S., Cox, M. L., Becerra, D. C., Watson, J. A., Voigt, S. L., Yerokun, B. A., … Hartwig, M. G. (2018). Higher Use of Surgery Confers Superior Survival in Stage I Non-Small Cell Lung Cancer. Ann Thorac Surg, 106(5), 1533–1540. https://doi.org/10.1016/j.athoracsur.2018.05.066
Mulvihill, Michael S., Morgan L. Cox, David C. Becerra, Joshua A. Watson, Soraya L. Voigt, Babatunde A. Yerokun, Paul J. Speicher, Thomas A. D’Amico, Betty Tong, and Matthew G. Hartwig. “Higher Use of Surgery Confers Superior Survival in Stage I Non-Small Cell Lung Cancer.Ann Thorac Surg 106, no. 5 (November 2018): 1533–40. https://doi.org/10.1016/j.athoracsur.2018.05.066.
Mulvihill MS, Cox ML, Becerra DC, Watson JA, Voigt SL, Yerokun BA, et al. Higher Use of Surgery Confers Superior Survival in Stage I Non-Small Cell Lung Cancer. Ann Thorac Surg. 2018 Nov;106(5):1533–40.
Mulvihill, Michael S., et al. “Higher Use of Surgery Confers Superior Survival in Stage I Non-Small Cell Lung Cancer.Ann Thorac Surg, vol. 106, no. 5, Nov. 2018, pp. 1533–40. Pubmed, doi:10.1016/j.athoracsur.2018.05.066.
Mulvihill MS, Cox ML, Becerra DC, Watson JA, Voigt SL, Yerokun BA, Speicher PJ, D’Amico TA, Tong B, Hartwig MG. Higher Use of Surgery Confers Superior Survival in Stage I Non-Small Cell Lung Cancer. Ann Thorac Surg. 2018 Nov;106(5):1533–1540.
Journal cover image

Published In

Ann Thorac Surg

DOI

EISSN

1552-6259

Publication Date

November 2018

Volume

106

Issue

5

Start / End Page

1533 / 1540

Location

Netherlands

Related Subject Headings

  • United States
  • Treatment Outcome
  • Survival Analysis
  • Risk Assessment
  • Retrospective Studies
  • Respiratory System
  • Proportional Hazards Models
  • Prognosis
  • Pneumonectomy
  • Multivariate Analysis